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Mutations in the DYSF gene, encoding dysferlin, cause muscular dystrophies in man. We compared 4 dysferlinopathic mouse
strains: SJL/J and B10.SJL-Dysfim/AwaJ (B10.SJL), and A/J and B6.A-Dysfprmd/GeneJ (B6.A/J). The former but not the latter
two are overtly myopathic and weaker at 3 months of age. Following repetitive large-strain injury (LSI) caused by lengthening
contractions, all except B6.A/J showed ∼40% loss in contractile torque. Three days later, torque in SJL/J, B10.SJL and controls,
but not A/J, recovered nearly completely. B6.A/J showed ∼30% torque loss post-LSI and more variable recovery. Pre-injury, all
dysferlinopathic strains had more centrally nucleated ﬁbers (CNFs) and all but A/J showed more inﬂammation than controls.
At D3, all dysferlinopathic strains showed increased necrosis and inﬂammation, but not more CNFs; controls were unchanged.
Dystrophin-null DMDmdx mice showed more necrosis and inﬂammation than all dysferlin-nulls. Torque loss and inﬂammation on
D3 across all strains were linearly related to necrosis. Our results suggest that (1) dysferlin is not required for functional recovery 3
days after LSI; (2) B6.A/J mice recover from LSI erratically; (3) SJL/J and B10.SJL muscles recover rapidly, perhaps due to ongoing
myopathy; (4) although they recover function to diﬀerent levels, all 4 dysferlinopathic strains show increased inﬂammation and
necrosis 3 days after LSI.
1.Introduction
The DYSF gene encodes dysferlin, a tail-anchored integral
membrane protein of 230kDa that is thought to mediate
membrane stability or fusion through the action of calcium-
binding C2 domains in its large cytoplasmic region [1–3].
Mutations in dysferlin have been linked to several muscular
dystrophies in man, including limb girdle muscular dystro-
phytype2B(LGMD2B)andMiyoshimyopathy(MM)[4,5].
There are currently no treatments for these diseases, but
several therapeutic approaches have been tested in vitro and
in mice, including gene therapeutic studies. The success of
these experiments and their ultimate translation to the clinic
will rely on the availability of murine models of the human
dysferlinopathies. Several such models exist, including two
that, like the human dystrophies, arose spontaneously and
two that were generated by targeted gene ablation [6, 7].
Although some of the properties of these strains of dys-
ferlinopathic mice have been described, very few of their
characteristics have been directly compared to determine
which, if any, most closely reproduce the characteristics of
LGMB2B/MM. Here, we report the results of comparative
studies on the two spontaneously occurring murine dysferlin
mutants, SJL/J and A/J, and of the two strains derived from
these mutants by breeding them into C57Bl mice, B10.SJL-
Dysfim/AwaJ and B6.A-Dysfprmd/GeneJ (referred to in this
paper as B10.SJL and B6.A/J, resp.).
SJL/J mice show spontaneous myopathy [7–9], due to
a mutation in the Dysf gene that results in the deletion
of an exon encoding 57 amino acids in one of dysferlin’s
C2 domains [10, 11]. This mutation leads to a ∼6-fold or
greater reduction in dysferlin levels in SJL/J muscle [7, 12]
and is associated with the development of ﬁber necrosis, cen-
tral nucleation, inﬂammation, elevation of serum creatine
kinase, and, in some muscles, fatty inﬁltration [13]. Some
phenotypic changes occur in mice as early as 3 weeks of
age and additional changes, including increases in centrally
nucleated ﬁbers (CNFs), are evident in 2-month-old mice2 Journal of Biomedicine and Biotechnology
[9, 10, 12, 13]. The myopathy becomes more prominent with
age,withameasurablelossofstrengthat6monthsofageand
even greater compromise of histopathology and function in
older animals [9, 13]. However, when compared to control
strains, SJL/J mice also show behavioral diﬀerences, a high
incidence of reticulum cell sarcomas [14], elevated levels of
circulating T cells, and greater susceptibility to autoimmune
diseases (http://jaxmice.jax.org/strain/000686.html). These
traits are probably not linked to its dystrophic phenotype,
which has been bred into the C57Bl/10J background [10,
12]. Extensive comparisons of SJL/J mice with their B10.SJL
counterpartshavenotbeenreported,butpreliminarystudies
ofthetime courseof development of overt myopathyand the
nature of the myopathy in these strains seem similar [9, 12].
They also share the property that proximal muscles, such
as the quadriceps femoris, are more severely aﬀected than
distalmuscles,suchasthegastrocnemiusandtibialisanterior
[9, 12].
A/J, the other spontaneous dysferlinopathic mouse, has
an ETn retrotransposon insertion in intron 4 of the murine
Dysf gene that leads to the complete absence of dysferlin as
assayed by immunoblots [7]. Paradoxically, the A/J mouse
shows a milder phenotype at young ages and only becomes
overtly myopathic at ages approaching 1yr [7]. Nevertheless,
serum creatine kinase is as elevated in 1-month-old A/J mice
as it is in SJL/J mice [7]. As also seen in SJL/J and B10.SJL
mice (see above), the eﬀect of the A/J mutation is more pro-
n o u n c e di np r o x i m a lt h a ni nd i s t a lm u s c l e s[ 7]. Ultrastruc-
tural images of A/J muscle, like those of SJL/J and dysferlin-
null mice and human dysferlinopathies [6, 7, 15], show
lesions in the sarcolemma and the accumulation of mem-
brane-bound vesicles nearby as well as changes in the basal
lamina [7]. Comparisons of A/J mice with mice carrying the
same retrotransposon element in the C57Bl/6J background,
B6.A/J, suggest that the hindlimb muscles of the latter
develop myopathy more rapidly than A/J mice [16–18]. A/J
mice carry a number of other mutations, however, that lead
to hearing loss, a high incidence of lung carcinomas, lack of
complement 5, and resistance to diabetes (http://jaxmice
.jax.org/strain/000646.html). They also show much lower
levels of spontaneous motor activity than many other strains
of mice. These characteristics, or others, may modulate the
extent and development of dysferlinopathy in A/J mice.
Our earlier studies, which focused on the A/J strain,
showed that eccentric injuries caused by repetitive large-
strain lengthening contractions had distinct eﬀects on the
ankle dorsiﬂexor muscles of A/J mice, compared to several
control strains. In particular, both the A/J and control mice
were equally susceptible to the large-strain injury, losing 40–
50% of the contractile torque of their ankle dorsiﬂexors.
Immediately after injury and for several days thereafter, the
myoﬁbers of A/J mice retained 10kDa ﬂuorescein-dextran,
to the same extent as controls, suggesting that they had res-
ealed their injured sarcolemmal membranes as well as
controls. We interpreted these results to mean that, contrary
to the conclusions reached by earlier studies performed on
isolated myoﬁbers in vitro [6], dysferlin is not needed for
repairing sarcolemma damaged by a physiological injury
in vivo.D i ﬀerences between controls and A/J appeared
subsequent to injury, however, as controls recovered within
3 days of the injury, with little necrosis or inﬂammation and
withoutrequiringmyogenesis,whereastheA/Jmicerequired
several weeks to recover, due to extensive ﬁber loss following
necrosis and massive inﬂammation and subsequent regener-
ation via myogenesis.
Here we compare the responses of the four strains of
mice, A/J, B6.A/J, SJL/J, and B10.SJL, to injury caused by
large-strain lengthening contractions. In particular, we com-
pare their baseline torque generated by the ankle dorsiﬂexor
group, the susceptibility to injury of this muscle group to
repetitive large-strain lengthening contractions, the recovery
of torque 3 days after injury, and the histological status of the
musclesbeforeandafterinjury,includingassessmentsofcen-
tral nucleation, necrosis and inﬂammation. Our results sug-
gest that the B6.A/J, SJL/J, and B10.SJL all recover from the
injury within 3 days following injury, whereas A/J do not.
Nevertheless, the response of the B6.A/J is distinct from that
of SJL/J and B10.SJL. We also compare our ﬁndings on dys-
ferlinopathicmicewithdystrophin-deﬁcientC57BL/10ScSn-
Dmdmdx/J mice (DMDmdx). We conclude that the dysfer-
linopathic strains of mice examined in this study are useful
for studying diﬀerent stages in the development of dysfer-
linopathy and the altered response to contraction-induced
injury in the absence of dysferlin.
2.MaterialsandMethods
We studied baseline contractile torque, change in torque fol-
lowing large-strain lengthening contractions, and histologi-
cal changes 3 days after injury in 4 diﬀerent murine models
ofdysferlindeﬁciencyandcomparedthemtotheirrespective
control strains and a murine model of dystrophin deﬁciency.
All mice used in this study were obtained either directly
from the Jackson Laboratory (Bar Harbor, ME) or were
obtained from our animal colonies set up from breeding
pairs initially obtained from the Jackson Laboratory (see
Table 1). Mice used for this study were males between
12–16wks of age. All experimental protocols involving
animals were approved by the Institutional Animal Care and
Use Committee of the University of Maryland School of
Medicine, Baltimore.
2.1. Torque Measurement and Large-Strain Injury (LSI).
Measurements of contractile torque and large-strain injury
were performed in vivo as described [17–20] with the Small-
animal Unit for Muscle Injury, Muscle Testing and Muscle
Training (SUMITT, patent pending). Brieﬂy, an anesthetized
animal was placed on its back with its foot strapped onto a
footplate in series with a torque transducer. The tibia was
stabilized with a pin. The dorsiﬂexor muscles were stimu-
lated via the peroneal nerve with a bipolar transcutaneous
electrode. Twitches elicited by single 0.1ms pulses were used
to optimize electrode placement, current amplitude, and
the optimal tibiotarsal angle for the dorsiﬂexors (typically
110◦ of plantarﬂexion). Post-LSI torque was measured at
the same preinjury testing angle. In this study we did not
test if LSI alters the torque-angle relationship of the dorsi-
ﬂexors although our unpublished data suggest no change inJournal of Biomedicine and Biotechnology 3
Table 1: Mouse strains. Mouse strains used in the study and number of animals studied per strain.
Strain Source JAX mice
database stock # DYSF mutation N
A/WySnJ
School of Medicine University of
Maryland. Breeding pairs from The
Jackson Laboratory
000647 N/A. Control strain for A/J mice 8
A/J
School of Medicine University of
Maryland. Breeding pairs from The
Jackson Laboratory
000646
A retrotransposon insertion
within intron 4, causing aberrant
splicing of the gene
8
C57Bl/6J The Jackson Laboratory 000664 N/A. Background strain for
B6.A/J 8
B6.A/J
School of Medicine University of
Maryland. Breeding pairs from The
Jackson Laboratory
012767 B6.A-
Dysfprmd/GeneJ
Progressive muscular dystrophy
(prmd) allele from A/J
introgressed into the C57BL/6J
genetic background
8
SWR/J The Jackson Laboratory 000689 N/A. Control strain for SJL/J
mice 8
SJL/J The Jackson Laboratory 000686
171 bp in-frame deletion in the
encoded mRNA is predicted to
remove 57 amino acids from
dysferlin
8
C57BL/10J The Jackson Laboratory 000665 Background strain for B10.SJL 8
B10.SJL
School of Medicine University of
Maryland. Breeding pairs from The
Jackson Laboratory, and Dr. A. J. Wagers,
Harvard University, Cambridge, MA.
011128 B10.SJL-
Dysfim/AwaJ
DYSF mutation (inﬂammatory
myopathy, im) in the SJL strain
introgressed into the
C57BL/10ScSnHim strain and
subsequently bred to C57Bl/10J
8
DMDmdx
School of Medicine University of
Maryland. Breeding pairs from The
Jackson Laboratory
001801
C57BL/10ScSn-
Dmdmdx/J
N/A. Dystrophin-deﬁcient mice.
C-to-T transition at position
3185, resulting in a termination
codon in place of a glutamine
codon
8
A/WySnJ and A/J after LSI. Increasing frequencies of pulses
within a 300ms pulse train were used to determine optimal
tetanic frequency, which was 80 or 90Hz for all control
strains and A/J and 100–125Hz for all other strains. After
optimal baseline torque (maximal twitch and tetany) was
recorded, 20 lengthening contractions were induced in the
dorsiﬂexors by moving the foot into plantarﬂexion from 90–
180◦ (starting with foot orthogonal to tibia) at 1200◦/s, while
the dorsiﬂexors were tetanically stimulated. While the 180◦
of plantarﬂexion is unlikely to occur in mice during normal
motor activity, our injury model is physiological as it is does
not exceed the maximal range of plantarﬂexion of the ankle-
foot complex recorded through gentle passive movement. A
rest period of 1min was allowed between successive length-
ening contractions. Torques after LSI were recorded 4min
after the last lengthening contraction. Contractile data in
Figures 1 and 2 are from 6 animals that were studied lon-
gitudinally on the day of injury (D0) and 3 days later (D3).
Weperformedaterminalstudyontwoanimalsofeachstrain
at D0 to analyze histological changes immediately following
injury (middle panels in Figure 3; contractile data from these
animals are not shown).
2.2.HistologicalStudies. Histologicalstudieswereperformed
on the Tibialis anterior (TA) muscle, as it accounts for nearly
90% of the force produced by the dorsiﬂexors in mice [21].
Control and injured muscles were harvested from 2 animals
per strain ∼10min after injury on D0 and from 6 animals
perstrainatD3forhistologicalstudies. Collectionofunﬁxed
tissue, hematoxylin and eosin (H & E) staining, and labeling
of macrophages with rat anti-mouse antibodies to CD68,
which labels all murine macrophages [22], were performed
as described [18, 23]. Quantitative data from H & E staining
are from 8–10 unique visual ﬁelds (20x objective) from 3
diﬀerent animals and expressed as a percentage of the total
number of myoﬁbers counted (∼500 ﬁbers counted for each
strain of mice). Macrophage counts are from 3 animals per
strain from 4 unique visual ﬁelds (40x objective) per muscle
and expressed as the number of cells per square mm.
2.3. Statistical Methods. All statistical analyses were per-
formed with SigmaStat (Ashburn, VA). Baseline torque data
were analyzed with a one-way ANOVA, injury and recovery
data were analyzed with a repeated measures two-way
ANOVA. CNFs, necrotic ﬁbers and macrophage counts
(CD68+ cells) were analyzed by two-way ANOVAs. Post hoc
analyses were performed according to the Student-Newman-
Keuls method. Linear regression analyses of the eﬀect of
n e c r o s i sa n dm a c r o p h a g ec o u n t st o r q u ea sw e l lt h ee ﬀect
of macrophage counts on necrosis were performed with4 Journal of Biomedicine and Biotechnology
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Figure 1: Baseline torque before large-strain injury. Maximum iso-
metric tetanic torque of the dorsiﬂexor muscle group was measured
prior to LSI. All control strains (A/WySnJ, C57Bl/6J, SWR/J, and
C57Bl10/J) produced a similar level of contractile torque. Among
the Dysf mutants, only SJL/J mice and B10.SJL mice were weaker
than their corresponding controls. SJL/J mice were also weaker
than A/J mice. Raw torque produced by DMDmdx was the highest
amongthestudiedstrainsofmice. ∗Signiﬁcantdiﬀerencecompared
to control strain at same time point. NS:no signiﬁcant diﬀerence.
‡Signiﬁcant diﬀerence compared to A/J at same time point.
SigmaStat. Alpha was set at 0.05 ap r i o r i ,a n dP values less
than 0.05 were considered signiﬁcant. Physiological data are
reported as mean ± S.D., and histological data are reported
as mean ± S.E.M.
3. Results
We used established physiological and morphological meth-
ods to compare 4 strains of dysferlin-deﬁcient mice, A/J
and SJL/J, which carry diﬀerent mutations of dysferlin, and
B6.A/JandB10.SJL,whichcarrytheirrespectivemutationsin
the C57Bl/6J and C57Bl/10J backgrounds. We used the latter
as controls as well as SWR/J and A/WySnJ mice as controls in
our studies of SJL/J and A/J mice, respectively (see Table 1).
Our physiological experiments measured the contractile
torque generated by the ankle dorsiﬂexor muscles, the loss
of torque following a large-strain injury caused by repeated
lengthening contractions, and the recovery of torque 3 days
after injury. Our histological experiments measured the
number of CNFs, necrotic myoﬁbers, and inﬂammatory ma-
crophages in TA muscles before and after injury. Our results
indicate that these 4 strains of dysferlinopathic mice share
some important features but diﬀer signiﬁcantly in others.
3.1. Physiological Assays. We ﬁrst measured the torque
generated by the ankle dorsiﬂexor muscles of the 4 types of
dysferlinopathic mice, compared to the appropriate control
strains (Figure 1). All control strains were statistically in-
distinguishable from each other. There was no statistical
diﬀerence between A/J mice and its control, A/WySnJ mice,
0
20
40
60
80
100
120
T
o
r
q
u
e
 
(
p
r
e
i
n
j
u
r
y
 
(
%
 
)
)
A
/
W
y
S
n
J
 
D
0
A
/
J
 
D
0
C
5
7
B
l
/
6
J
 
D
0
B
6
.
A
/
J
 
D
0
S
W
R
/
J
 
D
0
S
J
L
/
J
 
D
0
C
5
7
B
l
/
1
0
J
 
D
0
B
1
0
.
S
J
L
 
D
0
A
/
W
y
S
n
J
 
D
3
A
/
J
 
D
3
C
5
7
B
l
/
6
J
 
D
3
B
6
.
A
/
J
 
D
3
S
W
R
/
J
 
D
3
S
J
L
/
J
 
D
3
C
5
7
B
l
/
1
0
J
 
D
3
B
1
0
.
S
J
L
 
D
3
D
m
d
m
d
x
D
0
D
m
d
m
d
x
D
3
∗
∗
∗
†
†
#
# # # #
#
#
#
#
‡
‡
Figure 2: Torque after LSI. We measured maximum isometric
torque ∼4min after the last lengthening contraction in the LSI
protocol (D0) and again 3 days later (D3). All control strains lost
a similar level of torque. All dysferlin mutant mice except B6.A/J
showed a similar reduction in torque immediately after injury;
B6.A/J mice showed less susceptibility to initial injury compared
to control C57Bl/6J mice as well as other dysferlinopathic strains.
DMDmdx mice showed the highest level of torque loss immediately
after injury. At D3, all control strains recovered to near baseline
torque levels. All dysferlin mutants except A/J recovered to similar
levelsastheirrespectivecontrolstrains.A/JmiceandDMDmdx mice
showed a signiﬁcant torque deﬁcit at D3. ∗Signiﬁcant diﬀerence
compared to control strain at same time point. #Signiﬁcant
diﬀerence within same strain between D0 and D3. †Signiﬁcant
diﬀerence compared to same Dysf mutation at same time point.
‡Signiﬁcant diﬀerence compared to A/J at same time point.
and between B6.A/J and its control, C57Bl/6J. SJL/J and
B10.SJL mice generated similar levels of torque, but were
weaker than their respective control strains, SWR/J and
C57Bl/10J. All dysferlinopathic strains and their controls
were signiﬁcantly weaker than DMDmdx mice, consistent
with earlier reports that the latter are stronger than controls
[24–26]. When normalized to muscle weight, however (see
Table 2), TA muscles of DMDmdx mice were ∼38% weaker
than muscles of C57Bl/10J mice.
We next subjected each murine strain to our large-strain
injury protocol (LSI, see Methods). All strains except B6.A/J
lost ∼40% of their preinjury torque after LSI (Figure 2).
B6.A/J mice only lost ∼30% of their baseline torque, which
was signiﬁcantly less than its control C57Bl/6J and all other
strains (Figure 2; supplementary data, Figures S1 and S2
available online at doi:10.1155/2011/134031). In contrast
to all the control and dysferlinopathic strains we assayed,
DMDmdx mice showed a ∼80% loss of contractile torque
after LSI, signiﬁcantly greater than any of the other strains,
consistent with the greater susceptibility to injury by length-
ening contractions characteristic of these mice [27–29].
We assayed the ability of mice of each strain to recover
from the large-strain injury within the 3-day period that
we previously found was suﬃcient for controls [17–19].Journal of Biomedicine and Biotechnology 5
Table 2: Weights of TA muscles. Wet weights (in mg) of uninjured (right) and injured (left) TA muscles collected at D3 are given.
A/Wy SnJ A/J C57Bl/6J B6.A/J SWR/J SJL/J C57Bl/10J B10.SJL DMDmdx
N 4444 3 3 3 33
D3 control 43 ± 14 2 ±15 1 ±14 8 ±14 5 ±45 0 ±24 3 ±24 5 ±17 9 ±2
D3 injured 45 ± 34 0 ±15 2 ±14 7 ±24 7 ±54 8 ±44 5 ±24 6 ±17 5 ±4
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Figure 3: Histology before and after injury. We labeled TA muscles with H&E stains. In uninjured muscle, necrotic ﬁbers identiﬁed by
pale, disrupted cytoplasmic staining and inﬁltrated by mononuclear cells appeared in all dysferlinopathic strains except A/J (red arrows).
All dysferlin mutants had many CNFs (blue arrow heads) before LSI. At D3 post-LSI, necrotic ﬁbers increased in all mutants, with the most
widespread area of necrosis in A/J muscle. Extensive myoﬁber damage soon after LSI was visible in DMDmdx muscle, but not in control or
dysferlinopathic muscle.
The mean torque for C57Bl/6J mice exceeded 100% baseline
torque, suggesting complete recovery of function 3 days after
LSI. All other control strains were statistically indistinguish-
able from C57Bl/6J at D3 post-LSI, indicating that they too
had regained all of their lost contractile torque (Figure 2).
As reported [17–19], A/J mice only recovered to only ∼70%
of their preinjury torque, equivalent to ∼1/4 of the torque
lost immediately after LSI. Surprisingly, B10.SJL and SJL/J
recovered to ∼90% of their original torque by D3 (Figure 2),
which was also statistically indistinguishable from the level
of recovery shown by their respective control strains. This
suggests that the absence or severe depletion of dysferlin is
not suﬃcient to delay the recovery of torque 3 days after
large-strain injury. The group mean for contractile torque
for B6.A/J also recovered as well as their control C57Bl/6J
mice. However, their recovery at D3 showed a wide range of
values from a loss of 8% below initial injury in one animal to
a gain of 10% above preinjury torque in another. Due to the
high level of variability seen in the set of 6 B6.A/J animals,
we performed physiological measurements on additional6 Journal of Biomedicine and Biotechnology
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Figure 4: Macrophages (CD68+ cells) in muscle before and after injury. We labeled cross sections of uninjured and injured TA muscles with
antibodies to CD68 to identify macrophages (red) and DAPI to mark nuclei (blue). Focal areas of macrophage inﬁltration were evident in
uninjured muscle of all dysferlinopathic strains as well as DMDmdx mice. At D3 following LSI, macrophage numbers increased signiﬁcantly
in these mutant strains.
sets of animals. With increased sample size, B6.A/J were
statistically indistinguishable from C57Bl/6J and A/J at D0,
but were diﬀerent from both these strains at D3. They were
also more variable (supplementary data, Figures S1 and S2).
Just as they diﬀered in their initial torque and susceptibility
to injury, DMDmdx mice also diﬀered signiﬁcantly from
the control and dysferlinopathic strains in their extent of
recovery from LSI, reaching only ∼60% of their original
torque by D3, equivalent to ∼1/2 of the torque lost initially.
3.2. Histological Studies. We assessed 3 diﬀerent morpholog-
ical markers of myopathy, CNFs and necrotic ﬁbers (both
quantitated from H&E-stained sections) and macrophages
(quantitated from sections immunolabeled with antibodies
to CD68), in uninjured TA muscles and in muscles 3 days
after injury (Figures 3 and 4). As all control strains were
statistically indistinguishable at D0 and D3 in the number
of CNFs, necrotic ﬁbers, and CD68+ cells, we only show
comparisons for these variables with C57Bl/6J data.
In uninjured muscles, CNFs were elevated in all dysfer-
linopathic mice as well as in DMDmdx (Figure 5), compared
to controls. Uninjured SJL/J muscle had more CNFs than
the other dysferlinopathic strains. We found no signiﬁcant
diﬀerences in central nucleation among B10.SJL, A/J, and
B6.A/J. DMDmdx mice showed much higher levels of CNFs,
consistent with earlier reports [30, 31]. Except for DMDmdx,
we observed no signiﬁcant increases in CNFs at D3 in any of
the strains.
Although necrotic ﬁbers were readily detected in the
uninjured TA muscles of B6.A/J, B10.SJL, and SJL/J mice,
the numbers were not signiﬁcantly greater than control
muscles (Figures 3 and 6). On D3 post-LSI, however, the
number of necrotic ﬁbers increased signiﬁcantly in all of
the dysferlinopathic mice (Figure 6). Necrotic ﬁbers at D3
in A/J and SJL/J muscles were statistically indistinguishable,
but B6.A/J and B10.SJL muscles had signiﬁcantly fewer
necrotic ﬁbers than A/J and SJL/J, respectively. DMDmdx
had the highest levels of necrosis, which can be explained
by severe myoﬁber damage seen immediately after injury, a
feature not seen in dysferlinopathic muscle (Figure 6; also
see middle panels in Figure 3). A regression analysis with %
necrotic ﬁbers as the independent variable and torque on D3Journal of Biomedicine and Biotechnology 7
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Figure 5:QuantitationofCNFs.WecountedCNFsinH&E-stained
cross sections of uninjured and injured TA muscles. In uninjured
muscles, CNFs were elevated in all dysferlin mutants, with SJL/J
muscle showing the greatest elevation. DMDmdx muscle showed
several-fold CNFs more than all the dysferlinopathic samples.
Except for DMDmdx, none of the strains showed changes in CNFs at
D3. ∗Signiﬁcant diﬀerence compared to control strain at same time
point. #Signiﬁcant diﬀerence within same strain between uninjured
and D3. †Signiﬁcant diﬀerence compared to same Dysf mutation at
same time point. ‡Signiﬁcant diﬀerence compared to A/J at same
time point. NS:no signiﬁcant diﬀerence.
as the dependent variable showed a linear relationship
(Figure 7;a d j u s t e dr2 = 0.904, P = 0.002). Thus, the deficit
in torque 3 days after LSI was directly proportional to the
number of necrotic myoﬁbers at D3. SJL/J alone fell above
the95%conﬁdenceintervalsuggestingthattheirD3contrac-
tiletorqueexceedswhatwouldbeexpectedbasedonthelevel
of necrosis. Consistent with this, SJL/J mice have been shown
t or e c o v e rf r o mo t h e rf o r m so fi n j u r yv e r ye ﬃciently [32].
Wealsoquantitatedthenumberofmacrophages(CD68+
cells) in TA muscles of each strain, both before and
after injury. Focal areas of necrosis in uninjured mus-
cles were invaded by macrophages in all dysferlinopathic
strains (Figure 4). However, macrophage counts were not
signiﬁcantly diﬀerent from uninjured C57Bl/6J (Figure 8).
All dysferlinopathic strains showed signiﬁcant increases in
macrophages at D3 post-LSI (Figure 8), with the highest
counts detected in A/J. DMDmdx muscle at D3 had signiﬁ-
cantly greater macrophage inﬁltration than A/J. Regression
analysis with D3 torque regressed on macrophage counts
showed a linear relationship (Figure 9(a); adjusted r2 =
0.836, P = 0.007), with all strains falling within the 95%
conﬁdence interval. Similarly, a regression analysis with
macrophage counts regressed on necrosis at D3 also showed
a linear relationship (Figure 9(b); adjusted r2 = 0.896, P =
0.003), with all strains falling within the 95% conﬁdence
interval.
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Figure 6: Quantitation of necrotic ﬁbers. We counted necrotic
ﬁbers in H&E-stained cross sections of uninjured and injured TA
muscles. Necrotic ﬁbers increased signiﬁcantly at D3 in all mutant
strains. A/J muscle showed the largest increase among the dysferlin
mutants, but the extent of necrosis in A/J muscles was signiﬁcantly
less than DMDmdx at this time point. ∗Signiﬁcant diﬀerence
compared to control strain at same time point. #Signiﬁcant diﬀer-
ence within same strain between uninjured and D3. †Signiﬁcant
diﬀerence compared to same Dysf mutation at same time point.
‡Signiﬁcant diﬀerence compared to A/J at same time point.
4. Discussion
Several strains of dysferlinopathic mice have been studied as
possible models of human muscular dystrophies linked to
mutations in the dysferlin gene. These include 2 diﬀerent
strains generated by gene ablation [6, 7], 2 strains with
spontaneous mutations in the dysferlin gene, A/J and SJL/J,
and the strains that were derived by breeding the A/J and
SJL/JDysf mutationsintothewell-establishedC57Bl/10Jand
C57Bl/6J genetic backgrounds, namely, B6.A/J and B10.SJL.
Although several laboratories have compared some of these
strains to each other, with results suggesting that they share
similar properties [7, 12, 13], few direct comparisons have
been made of mice carrying the SJL/J mutation to those
carrying the ETn retrotransposon of A/J, and none have
focused on their responses to injuries caused by lengthening
contractions. Here we provide evidence to suggest that SJL/J
and B10.SJL have a similar phenotype. We show further
that they diﬀer signiﬁcantly from A/J and B6.A/J mice and,
moreover, that the latter two strains diﬀer signiﬁcantly from
each other.
Our LSI protocol, which diﬀers from many other meth-
ods for injuring the hindlimb muscles of mice, has several
advantages, including rapidity and reproducibility. Our LSI
model also clearly distinguishes between some dysferlino-
pathic strains and controls, including A/J and A/WySnJ.
Furthermore,theLSImodelalsodistinguishesbetweensome
of the dysferlinopathic mice we have examined, discussed
further below, as well as between dysferlin-deﬁcient and
dystrophin-deﬁcient strains. LSI causes ∼2-fold greater force
deﬁcit immediately after LSI in muscles lacking dystrophin8 Journal of Biomedicine and Biotechnology
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Figure 7: D3 contractile torque regressed on necrosis. A regression
analysis of necrosis as the independent variable and D3 torque as
the dependent variable showed a good linear ﬁt, suggesting that
the extent of necrosis is a reliable negative predictor of functional
recovery at D3. The dashed and dotted lines represent the 95%
conﬁdence and prediction intervals, respectively.
than in muscles lacking dysferlin. Injury of DMDmdx muscle
is rapidly followed by signiﬁcant myoﬁber degeneration
(Figures2and3).DMDmdx miceareknowntobemuchmore
susceptible than controls to injury induced by lengthening
contractions [27–29], and the more pronounced eﬀectof LSI
on their muscles suggests that our injury model is indeed
physiologically relevant to the study of sarcolemmal damage
and repair.
Remarkably,however,althoughthephysiologicalchanges
induced by LSI diﬀer quantitatively from one strain to the
other, they are qualitatively similar in all the strains we
have studied, including control and dysferlinopathic strains.
These are indistinguishable in their susceptibility to initial
injurybutdiﬀer3dayslaterinnecrosisandinﬂammation.By
contrast, DMDmdx mice are more susceptible to initial injury
and also recover slowly. Consistent with this, regression
analyses of loss of function on D3 following LSI, measured
as torque loss, against the number of necrotic ﬁbers on D3,
show a strong linear correlation. Similarly, the number of
macrophages in muscles on D3 post-LSI is a linear function
of necrosis. In other studies, we have shown that the ap-
pearance of necrotic ﬁbers precedes the appearance of ma-
crophages in injured muscle by several hours (Roche JA and
Bloch RJ, in preparation). These results therefore suggest
that, despite the diﬀerent mutations and genes aﬀected in the
dysferlinopathic and dystrophinopathic mice we have stud-
ied, and the diﬀerent extents to which they recover contrac-
tile torque, the level of functional recovery and the extent
of inﬂammatory cell inﬁltration are determined by the
extent of myoﬁber necrosis. As macrophage inﬁltration in
3 dysferlinopathic strains (B6.A/J, SJL/J, and B10.SJL) is
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Figure 8: Quantitation of macrophages (CD68+ cells). We counted
macrophages in cross sections of uninjured and injured TA labeled
with antibodies to CD68 (see Figure 4). All dysferlin mutant strains
showed elevated macrophage counts at D3 post-LSI, with A/J
having signiﬁcantly higher levels than the other strains. DMDmdx
muscle showed signiﬁcantly higher macrophage inﬁltration than
A/J. ∗Signiﬁcant diﬀerence compared to control strain at same time
point. #Signiﬁcant diﬀerence within same strain between uninjured
and D3. †Signiﬁcant diﬀerence compared to same Dysf mutation at
same time point. ‡Signiﬁcant diﬀerence compared to A/J at same
time point.
signiﬁcantly elevated at D3 despite near complete functional
recovery and moderate levels of myoﬁber necrosis, our
results support a role for increased inﬁltration of monocytes
and macrophages in dysferlinopathies, as reported by others
[32–34].
Most of our attention in these studies was focused on
the properties of 4 diﬀerent dysferlinopathic strains of mice,
two carrying a retrotransposon in the dysferlin gene (A/J
and B6.A/J) and two carrying a mutation in the Dysf gene
that results in the deletion of an exon encoding 57 amino
acids in one of dysferlin’s C2 domains. We ﬁnd that the key
characteristics of the TA muscles of 12–16wk old SJL/J and
B10.SJL mice are low but readily detectable levels of central
nucleation, necrosis, and macrophage inﬁltration in unin-
jured muscles, consistent with the early stages of myopathy
reported in these mice at this age [9, 12]. Consistent with
their shared phenotypes, both strains lose similar fractions
of their initial torque after LSI, and they both recover
to near complete levels, similar to their respective control
strains, within 3 days. However, SJL/J muscles show greater
numbers of CNFs before injury and greater necrosis 3 days
after LSI, suggesting that genes other than dysferlin that are
diﬀerentially expressed play a role in the myopathy that has
been reported in SJL/J mice.
Our previous studies on the eﬀect of LSI on A/J and
A/WySnJ mice suggest that the presence or absence of dys-
ferlin does not have an immediate eﬀect on the ability of the
sarcolemma to reseal, trapping 10kDa ﬂuorescein dextran inJournal of Biomedicine and Biotechnology 9
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Figure 9: Regression analyses of contractile torque versus macrophage counts and macrophage counts versus necrosis. A regression analysis
of the number of macrophages on D3 as the independent variable and torque at D3 as the dependent variable showed a good linear ﬁt (a).
Similarly, analysis of the number of necrotic ﬁbers as the independent variable and the number of macrophages as the dependent variable
also showed a good linear ﬁt (b). The analyses suggest that that macrophage counts are a reliable negative predictor of functional recovery at
D3 and that the number of necrotic ﬁbers predicts the extent of macrophage invasion.
the myoplasm for several days after injury [18]. Rather, the
damage to dysferlin-null muscle is a later event, subsequent
to sarcolemmal resealing that manifests itself initially as
a signiﬁcant increase in necrosis followed later by increased
inﬂammation.ThesechangesarefullymanifestedbyD3after
LSI, after which damaged myoﬁbers are lost and replaced by
myogenesis. Our results with the SJL/J and B10.SJL indicate
that mutations in the dysferlin gene that reduce the levels
of dysferlin protein in muscle to ∼15% of control levels or
less [7, 12]a r en o ts u ﬃcient to lead to the persistent torque
deﬁcitseeninA/Jmuscle3daysafterinjury.However,despite
the near complete functional recovery of SJL/J and B10.SJL
muscles 3 days after injury, they still showed signiﬁcantly
elevated counts of necrotic ﬁbers and macrophages, albeit
less than A/J. They are nevertheless consistent with the idea
that wild-type dysferlin is not needed for sarcolemmal mem-
branes to reseal immediately after injury and protect ﬁbers
against rapid degeneration, as we see in dystrophin-deﬁcient
DMDmdx muscle. Indeed, the fact that these two strains of
mice recover torque equally well after injury, and nearly as
well as controls, suggests that the modiﬁed dysferlin they
synthesize, albeit in very low amounts, may promote their
accelerated recovery. Alternatively, the low levels of ongoing
degenerationandregeneration,evidentinuninjuredmuscles
of these mice from their elevated numbers of CNFs, necrotic
ﬁbers, and macrophages, may accelerate their recovery from
LSI, perhaps because they are already primed to regenerate.
Our current results with A/J and control, A/WySnJ, mice
agree with our previous results, which indicate that A/J but
not A/WySnJ muscle show more CNFs before injury, with
a large increase in necrosis and inﬂammation 3 days after
injury [18]. CNFs only increase at later times, as A/J muscles
regenerate [17, 18]. Consistent with this, torque is signiﬁ-
cantly depressed at D3 and recovers over 14 days after injury
as myogenesis is activated to replace ﬁbers lost as a result of
the pathological changes that follow LSI.
Although they carry the same retrotransposon as A/J
mice in their dysferlin gene and thus fail to express any
dysferlin [7], B6.A/J mice respond diﬀerently to LSI. In par-
ticular, although they have similar levels of CNFs, necrotic
ﬁbers, and inﬂammation both before and after injury, the
contractiletorqueswemeasurearehighlyvariable.Moreover,
their susceptibility to LSI appears lower than that of A/J mice
(aswellasSJL/JandB10.SJL),althoughthemagnitudeofthis
diﬀerencedecreasesasthesamplesizeincreases.Wecurrently
have no explanation for this variability. Until we can control
it, however, we favor the A/J line for studying the role of
dysferlin in muscles subjected to physiological injuries in
living mice.
Our results suggest that A/J mice, and SJL/J and B10.SJL,
are useful for studying diﬀerent aspects of the muscular
dystrophies linked to mutations in dysferlin. Because they
show an earlier onset of myopathy, typical of the human
disease, which is usually ﬁrst observed in young adults,
SJL/J and B10.SJL are potentially more useful for studying
the progression of the disease in vivo and for testing the
ability of drugs or other therapeutics to slow or block further
myopathic changes. Given that C57Bl/10J mice are a better
control for B10.SJL than SWR/J mice are for SJL/J, B10.SJL
mice are a better choice for these types of experiments. Such
studies will, however, require careful evaluation of the state
of the muscles before any treatment, as they may already10 Journal of Biomedicine and Biotechnology
be dystrophic. Because they show little pathology as young
adults, but respond so diﬀerently to LSI than controls, A/J
mice in our opinion remain very useful for studies designed
to examine the speciﬁc role of dysferlin in muscles without
the confounding eﬀect of preexisting dystrophic changes. A/J
mice also give insight into how apparently healthy muscles
lacking dysferlin become dystrophic, thus modeling the
subclinical phase of dysferlinopathies in humans. Given the
diﬀerences between them, however, it seems advisable for
laboratories to investigate both A/J and B10.SJL mice as they
search for a cure for dysferlinopathies.
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